DNA Synthesis Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
DNA Synthesis Market size will depict an 18.9% CAGR between 2024 and 2032 due to surging investments in biotechnology and healthcare infrastructure worldwide.
With a strong focus of companies on exploring ways to reduce waste and improve the efficiency of synthesis methods, there are significant developments in eco-friendly and sustainable DNA synthesis processes. The rise in strategic partnerships and collaborations to expand capabilities, enhance technology offerings, and enter new markets will also boost industry growth. For example, in April 2022, DNA Script partnered with Asia-Pacific distributors in line with global expansion plans to match the requirements for same-day enzymatic DNA synthesis.
The industry is segmented into service, method, application, end-use, and region.
By method, the DNA synthesis industry value from the chip-based synthesis segment will accrue a lucrative growth rate through 2032 due to higher application in fields, such as genomics, biotechnology, pharmaceuticals, and diagnostics. Chip-based synthesis, due to its miniaturized design, optimizes space and resource utilization. This compactness also facilitates scalability, whilst streamlining the production of DNA in bulk for diverse applications.
With respect to application, the DNA synthesis market size from the therapeutics segment will exhibit a remarkable CAGR from 2024-2032. The growth can be attributed to the surging need to create therapeutic genes that can be delivered into cells to treat genetic disorders and modify cells for therapeutic purposes. Moreover, synthetic DNA is used in the discovery and development of new drugs, particularly in understanding genetic targets and pathways involved in diseases.
Regionally, the Europe DNA synthesis industry share will witness significant growth through 2032. As personalized medicine is gaining traction in the region, there is an increasing demand for custom DNA synthesis, pivotal in crafting gene therapies, targeted treatments, and tailored vaccines. Several European companies are focusing on delivering tailored DNA sequences to meet these burgeoning needs.
DNA Synthesis Market size will depict an 18.9% CAGR between 2024 and 2032 due to surging investments in biotechnology and healthcare infrastructure worldwide. With a strong focus of companies on exploring ways to reduce waste and improve the efficiency of synthesis methods, there are significant developments in eco-friendly and sustainable DNA synthesis processes. The rise in strategic partnerships and collaborations to expand capabilities, enhance technology offerings, and enter new markets will also boost industry growth. For example, in April 2022, DNA Script partnered with Asia-Pacific distributors in line with global expansion plans to match the requirements for same-day enzymatic DNA synthesis. The industry is segmented into service, method, application, end-use, and region. By method, the DNA synthesis industry value from the chip-based synthesis segment will accrue a lucrative growth rate through 2032 due to higher application in fields, such as genomics, biotechnology, pharmaceuticals, and diagnostics. Chip-based synthesis, due to its miniaturized design, optimizes space and resource utilization. This compactness also facilitates scalability, whilst streamlining the production of DNA in bulk for diverse applications. With respect to application, the DNA synthesis market size from the therapeutics segment will exhibit a remarkable CAGR from 2024-2032. The growth can be attributed to the surging need to create therapeutic genes that can be delivered into cells to treat genetic disorders and modify cells for therapeutic purposes. Moreover, synthetic DNA is used in the discovery and development of new drugs, particularly in understanding genetic targets and pathways involved in diseases. Regionally, the Europe DNA synthesis industry share will witness significant growth through 2032. As personalized medicine is gaining traction in the region, there is an increasing demand for custom DNA synthesis, pivotal in crafting gene therapies, targeted treatments, and tailored vaccines. Several European companies are focusing on delivering tailored DNA sequences to meet these burgeoning needs.
- Chapter 1 Methodology and Scope
- 1.1 Market scope and definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
- Chapter 2 Executive Summary
- 2.1 Industry 360°synopsis
- Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Growing prevalence of diseases globally
- 3.2.1.2 Rapid technology advancements in the field of synthetic biology
- 3.2.1.3 Rising investments towards research and development (R and D) activities
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Stringent government regulations and guidelines
- 3.2.2.2 High cost, potential biosafety, biosecurity and ethical issues
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 U.S.
- 3.4.2 Europe
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
- Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.1.1 Thermo fisher scientific Inc.
- 4.1.2 Eurofins scientific
- 4.1.3 GenScript biotech corporation
- 4.2 Company matrix analysis
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
- Chapter 5 Market Estimates and Forecast, By Service, 2018 – 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Oligonucleotide synthesis
- 5.2.1 Standard oligonucleotide synthesis
- 5.2.2 Custom oligonucleotide synthesis
- 5.3 Gene synthesis
- 5.3.1 Custom gene synthesis
- 5.3.2 Gene library synthesis
- Chapter 6 Market Estimates and Forecast, By Method, 2018 – 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Solid-phase synthesis
- 6.3 PCR-based enzyme synthesis
- 6.4 Chip-based synthesis
- Chapter 7 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Research and development
- 7.3 Diagnostics
- 7.4 Therapeutics
- Chapter 8 Market Estimates and Forecast, By End use, 2018 – 2032 ($ Mn)
- 8.1 Key trends
- 8.2 Biopharmaceutical companies
- 8.3 Academic and research institutes
- 8.4 Contract research organizations
- Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
- 9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 Rest of Middle East and Africa
- Chapter 10 Company Profiles
- 10.1 BIOMATIK
- 10.2 Bioneer Corporation
- 10.3 Eton Bioscience, Inc.
- 10.4 Eurofins Scientific
- 10.5 GenScript Biotech Corporation
- 10.6 IBA Lifesciences GmbH
- 10.7 Integrated DNA Technologies, Inc.
- 10.8 Kaneka Eurogentec S.A.
- 10.9 LGC Biosearch Technologies
- 10.10 OriGene Technologies, Inc.
- 10.11 ProMab Biotechnologies, Inc.
- 10.12 ProteoGenix
- 10.13 Quintara Biosciences
- 10.14 Synbio Technologies
- 10.15 Thermo Fisher Scientific Inc.
- 10.16 Twist Bioscience Corporation
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook